Joy Kong, MDRegenerative Medicine Physician, Educator, and Entrepreneur

Peptides #shorts

22 Dec 2023 · 1 min

Watch on YouTube

0:39

A 10-year study of 79 patients with coronary artery disease found that those given apetalon peptide every six months showed cardiovascular function equivalent to being nine years younger than untreated patients.

Questions this video answers

60 to 69 years

About half of the 79 patients (≈39–40) received apetalon

10 milligrams, given every three days during a 15-day course

Six courses total, administered every six months (spanning three years)

Chapters

A cool study is a study of 79 patients with coronary artery disease, and they're aged 60 to 69, where half of them received six courses of apetalon at 10 milligrams every three days for 15 days. So that's one course only for 15 days. And every six months they do another one. So they only did it six times. That's three years. And they were monitored for 10 years. So the apatylon group, and when you look at their cardiovascular function, they were nine years younger than the ones that did not get this peptide.